The findings show the importance of preventing bone disease in multiple myeloma (MM), the authors said.
Due to the nature of the disease, multiple myeloma (MM) causes lytic bone lesions and fractures, but the impact of fractures on survival is unknown. A recent study indicates that patients with MM and fractures are at a significantly increased risk of death compared with patients who do not have fractures.
Patients with MM and bone disease have a reduced quality of life, as the interaction between malignant plasma cells in the bone marrow and the bone microenvironment leads to the destruction of bone and reduced osteoblast function, as well as blocking of bone repair. Fractures may be caused by decreased bone mineral density and treatment with glucocorticoids; in a previous population-based retrospective study, patients had a 9-fold increase in the risk of factors after MM diagnosis.
Using the Swedish Cancer Registry, researchers obtained data from patients with MM diagnosed between 1990 to 2013. Using a Cox regression model, researchers compared survival in patients with and without a fracture at MM diagnosis. Another Cox model was used with fracture as a time-dependent variable to assess the effect of fracture on survival after diagnosis.
A total of 14,013 patients were diagnosed during the study; 1213 (8.7%) were diagnosed with a fracture at the time of MM diagnosis, and 3235 (23.1%) after diagnosis.
The adjusted results showed that patients with a fracture at diagnosis were at a significantly increased risk of death (hazard ratio [HR], 1.28; 95% CI, 1.19-1.37). The risk of death was significantly increased in patients with a fracture after MM diagnosis (HR, 2.00; 95% CI, 1.90-2.10).
The impact of fractures on survival did not change significantly between the 2 calendar periods—1990-1999 and 2000-2013—in the study (HR, 0.98; 95% CI, 0.89-1.08).
The authors said that patients with MM with fractures are at a significantly increased risk of dying compared with those without fractures. The findings show the importance of preventing bone disease in multiple myeloma, they said
Reference
Thorsteinsdottir S, Gislason G, Aspelund T, et al. Fractures and survival in multiple myeloma: results from a population-based study [published online December 2, 2019]. Haematol. doi:10.3324/haematol.2019.230011.
DLBCL Outcomes Vary Sharply for Patients 80 Years and Older
April 16th 2025A majority of cases of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma globally, are diagnosed in patients 65 years and older; these patients are a heterogeneous group, and few studies have investigated how their outcomes are influenced by patient characteristics and care management regimens.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Ibrutinib May Boost Efficacy of Liso-Cel in CLL With Richter Transformation
April 10th 2025Patients with chronic lymphocytic leukemia (CLL) who experience Richter transformation have a poor prognosis, but ibrutinib may help boost the efficacy of chimeric antigen receptor T-cell therapies.
Read More